Essential History Expeditions Announces 2018 Historic Site Group Tours Schedule
Dec 19, 2017 14:01 pm UTC| Business
DENVER, Dec. 19, 2017 -- Essential History Expeditions, an adventure-based group tour company, announced today their 2018 schedule for exceptional educational historic site expeditions. Group tours include Vietnam, WWII...
Microdrones Earns Prestigious International Customer Service Certification
Dec 19, 2017 14:01 pm UTC| Business
SIEGEN, Germany, Dec. 19, 2017 -- Microdrones was honored to receive the TUV Certification that recognizes our services and products that meet and achieve customer expectations worldwide. For our customers, this proves...
Tim Matthews Joins Exabeam as Chief Marketing Officer
Dec 19, 2017 14:01 pm UTC| Business
SAN MATEO, Calif., Dec. 19, 2017 -- Exabeam, the leader in Security Intelligence Solutions, today announced that Tim Matthews has joined the company as chief marketing officer. In this role, he will drive global brand...
GPS Insight Named to Food Logistics’ 2017 FL100+ Top Software and Technology Providers
Dec 19, 2017 14:01 pm UTC| Business
SCOTTSDALE, Ariz, Dec. 19, 2017 -- GPS Insight, a leading provider of tailored GPS tracking and E-Log solutions for commercial fleets, was named to Food Logistics’ 2017 FL100+ Top Software and Technology Providers...
Bugcrowd Delivers Unmatched Visibility, Coverage and Control of Vulnerability Testing
Dec 19, 2017 14:01 pm UTC| Business
SAN FRANCISCO, Dec. 19, 2017 -- Bugcrowd, the leader in crowdsourced security, today announced the availability of Traffic Control. Built into Crowdcontrol™, a powerful all-in-one platform for simplified vulnerability...
Cherubim Interests, Inc. Address To Shareholders
Dec 19, 2017 14:01 pm UTC| Business
DALLAS, Dec. 19, 2017 -- Cherubim Interests, Inc. (OTC PINK:CHIT) ("the Company"), an expansion-stage alternative construction and real estate development company, announces its year-end letter to shareholders. ...
Dec 19, 2017 14:01 pm UTC| Business
BALTIMORE, Dec. 19, 2017 -- Asklepion Pharmaceuticals, LLC (“Asklepion” or “the Company”) announced that it has reached an agreement with the U.S. Food and Drug Administration (FDA) regarding a Special Protocol...